ArticleClinical drug investigation2025

Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in Australia.

Sarah Glewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.